Quince Therapeutics, Inc. (QNCX)
0.1094
+0.01
(+5.19%)
USD |
NASDAQ |
Mar 05, 16:00
0.1058
0.00 (0.00%)
After-Hours: 07:37
Quince Therapeutics Cash from Investing (Quarterly) : -1.781M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -1.244M |
| Masimo Corp. | -8.70M |
| Ocular Therapeutix, Inc. | -2.839M |
| Gossamer Bio, Inc. | 17.01M |
| Ernexa Therapeutics, Inc. | -0.022M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.928M |
| Cash from Financing (Quarterly) | 1.376M |
| Free Cash Flow | -38.98M |
| Free Cash Flow Per Share (Quarterly) | -0.1854 |
| Free Cash Flow to Equity (Quarterly) | -10.51M |
| Free Cash Flow to Firm (Quarterly) | -10.00M |
| Free Cash Flow Yield | -756.2% |